Author: Smith, Peter
Similar Items: The development, implementation and validation of a plasma-based high performance liquid chromatographic assay for Isoniazid and N-Acetylisoniazid: an acetylator status population study at Brewelskloof Hospital
- Isoniazid and acetylisoniazid urine concentrations as a maker of adherence to isoniazid preventative therapy in children
- Development and validation of liquid chromatography mass spectrometry (L/C/MS/MS) assay for the determination of plasma 4betahydroxycholestrol and cholesterol in HIV infected children in Africa
- The therapeutic importance of isoniazid metabolism in elderly patients
- Determinants and consequences of the pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in a cohort of tuberculosis patients
- A critical appraisal of the clinical pharmacokinetics of isoniazid
- The Development and Validation of a Direct LC-MS/MS Assay for the Determination of Tenofovir-diphosphate in Dried Blood Spots for the Analysis of Clinical Samples